Cutaneous Manifestations and Dermatologic Adverse Events in IBD: A Clinical Update.
Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are immune-mediated disorders characterized by chronic gastrointestinal inflammation and a broad spectrum of extraintestinal manifestations. Among these, dermatological manifestations significantly impact patients'...
| Publicado en: | Inflammatory Bowel Diseases Vol. 32; no. 3; pp. 542 - 562 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
Mar2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=192051049&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 192051049 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10780998 N0V jtl: Inflammatory Bowel Diseases issn: 10780998 maglogo: N pubinfo: dt: Mar2026 vid: 32 iid: 3 pid: 622 pub: Oxford University Press / USA artinfo: ui: 192051049 192051049 192051049 10.1093/ibd/izaf228 192051049 ppf: 542 ppct: 20 formats: tig: atl: Cutaneous Manifestations and Dermatologic Adverse Events in IBD: A Clinical Update. aug: au: Tsilimpotis, Dimitrios Kyriakou, Georgia Biedermann, Luc Vavricka, Stephan Greuter, Thomas Rogler, Gerhard Doulberis, Michael affil: Department of Dermatology, Medical School, University of Patras, 26504 Patras, Greece sug: subj: Inflammatory Bowel Diseases Complications Skin Diseases Etiology Biological Products Adverse Effects Crohn Disease Complications Crohn Disease Epidemiology Colitis, Ulcerative Complications Erythema Nodosum Epidemiology Erythema Nodosum Diagnosis Erythema Nodosum Therapy Pyoderma Gangrenosum Epidemiology Pyoderma Gangrenosum Diagnosis Pyoderma Gangrenosum Therapy Sweet's Syndrome Epidemiology Sweet's Syndrome Diagnosis Sweet's Syndrome Therapy Hidradenitis Suppurativa Epidemiology Hidradenitis Suppurativa Therapy Psoriasis Epidemiology Psoriasis Immunology Psoriasis Therapy Acne Rosacea Epidemiology Dermatitis, Atopic Epidemiology Vitiligo Diagnosis Chronic Urticaria Diagnosis Vasculitis Diagnosis Alopecia Areata Epidemiology Alopecia Areata Diagnosis Lupus Erythematosus, Systemic Drug Therapy Lupus Erythematosus, Systemic Chemically Induced Tumor Necrosis Factor Adverse Effects Antibodies, Monoclonal Adverse Effects Risk Assessment Herpes Zoster Epidemiology Herpes Zoster Diagnosis Herpes Zoster Prevention and Control Immunization Microbiota Immunology Cytokines Immunology Disease Susceptibility Biopsy Methods Ultrasonography Methods Magnetic Resonance Imaging Methods ab: Inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis, are immune-mediated disorders characterized by chronic gastrointestinal inflammation and a broad spectrum of extraintestinal manifestations. Among these, dermatological manifestations significantly impact patients' quality of life (QoL), presenting as conditions linked to IBD itself or IBD-related medical therapy. This comprehensive review underscores the relationship between IBD and cutaneous manifestations, with particular emphasis on erythema nodosum, pyoderma gangrenosum, Sweet syndrome, and hidradenitis suppurativa, alongside autoimmune conditions like psoriasis and vitiligo. The influence of biologic therapies, including both paradoxical skin reactions mimicking extraintestinal manifestations and nonspecific rashes, is also discussed, with a focus on the pathophysiological mechanisms and therapeutic approaches. Emerging evidence highlights the bidirectional interplay of gut-skin axis, with shared genetic, microbial, and immune pathways. Special considerations, such as pregnancy-related dermatoses, are included to provide a holistic view of this complex relationship. Improved comprehension of these manifestations not only emphasizes the necessity for interdisciplinary care, but also informs tailored therapies to address systemic inflammation while minimizing dermatological complications. This update offers practical insights and emerging evidence to guide clinicians in optimizing patient outcomes. pubtype: Academic Journal doctype: pictorial review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|